• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates.动脉粥样硬化性肾动脉狭窄继发缺血性肾病:临床与组织病理学相关性。
Nephrol Dial Transplant. 2010 Nov;25(11):3615-22. doi: 10.1093/ndt/gfq269. Epub 2010 May 25.
2
Atherosclerotic ischemic nephropathy. Epidemiology and clinical considerations.动脉粥样硬化性缺血性肾病。流行病学及临床考量
Urol Clin North Am. 1994 May;21(2):195-200.
3
Distinct renal injury in early atherosclerosis and renovascular disease.早期动脉粥样硬化和肾血管疾病中的不同肾损伤。
Circulation. 2002 Aug 27;106(9):1165-71. doi: 10.1161/01.cir.0000027105.02327.48.
4
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.高胆固醇血症合并肾动脉狭窄时肾脏结构改变的机制
Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1295-301. doi: 10.1161/01.ATV.0000077477.40824.52. Epub 2003 May 15.
5
[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].[卡托普利延缓自发性动脉高血压和阿霉素肾病大鼠慢性肾功能不全的进展]
Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. doi: 10.2298/sarh0204073j.
6
Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease.经活检证实的动脉粥样硬化性肾病的临床病理相关性:对动脉粥样硬化性肾血管疾病肾功能结局的影响
Nephrol Dial Transplant. 2001 Apr;16(4):765-70. doi: 10.1093/ndt/16.4.765.
7
[Ischemic renal disease: revascularization or conservative treatment?].缺血性肾病:血管重建术还是保守治疗?
Nefrologia. 2005;25(3):258-68.
8
Ischemic nephropathy in an elderly nephrologic and hypertensive population.老年肾脏病和高血压人群中的缺血性肾病
Am J Nephrol. 1998;18(3):221-7. doi: 10.1159/000013340.
9
[Atherosclerotic nephropathy in renal artery stenosis--from randomized studies to individualized therapy].肾动脉狭窄中的动脉粥样硬化性肾病——从随机研究到个体化治疗
Vnitr Lek. 2003 Mar;49(3):217-21.
10
Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.人肾闭塞性动脉粥样硬化性肾动脉狭窄下游的微血管重构和血管生成信号改变。
Nephrol Dial Transplant. 2022 Sep 22;37(10):1844-1856. doi: 10.1093/ndt/gfac156.

引用本文的文献

1
Renal Ischemia Induces Endoplasmic Reticulum Stress and Impairs the Reparative Potency of Scattered Tubular-Like Cells.肾缺血诱导内质网应激并损害散在的管状样细胞的修复能力。
Am J Nephrol. 2025 Apr 10:1-17. doi: 10.1159/000545795.
2
Predictors of kidney disease progression after renal artery stenting.肾动脉支架置入术后肾病进展的预测因素。
BMC Nephrol. 2025 Apr 3;26(1):175. doi: 10.1186/s12882-025-04097-0.
3
Chronic total occlusion of renal artery in symptomatic young patient with resistant hypertension: is a revascularization necessary or redundant?有症状的年轻顽固性高血压患者肾动脉慢性完全闭塞:血管重建是必要的还是多余的?
J Hypertens. 2025 Jan 1;43(1):163-167. doi: 10.1097/HJH.0000000000003846. Epub 2024 Sep 18.
4
Higher LDL-C/HDL-C Ratio Is Associated with Elevated HbA1c and Decreased eGFR Levels and Cardiac Remodeling in Elderly with Hypercholesterolemia.较高的低密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值与高胆固醇血症老年人的糖化血红蛋白升高、估算肾小球滤过率降低及心脏重塑有关。
J Cardiovasc Dev Dis. 2024 Apr 30;11(5):140. doi: 10.3390/jcdd11050140.
5
Kidney Intrinsic Mechanisms as Novel Targets in Renovascular Hypertension.肾脏内在机制在肾血管性高血压中的新靶点作用
Hypertension. 2024 Feb;81(2):206-217. doi: 10.1161/HYPERTENSIONAHA.123.21362. Epub 2023 Oct 23.
6
Efficacy of Human Embryonic Stem Cells Compared to Adipose Tissue-Derived Human Mesenchymal Stem/Stromal Cells for Repair of Murine Post-Stenotic Kidneys.人胚胎干细胞在修复小鼠狭窄后肾脏方面的功效优于脂肪组织来源的人间充质干细胞/基质细胞。
Stem Cell Rev Rep. 2023 Feb;19(2):491-502. doi: 10.1007/s12015-022-10443-8. Epub 2022 Sep 1.
7
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis.严重动脉粥样硬化性肾动脉狭窄患者经皮腔内肾动脉支架置入术前、后肾皮质血流灌注的动态变化
Chin Med J (Engl). 2022 Jul 21;135(13):1570-7. doi: 10.1097/CM9.0000000000002162.
8
Microvascular remodeling and altered angiogenic signaling in human kidneys distal to occlusive atherosclerotic renal artery stenosis.人肾闭塞性动脉粥样硬化性肾动脉狭窄下游的微血管重构和血管生成信号改变。
Nephrol Dial Transplant. 2022 Sep 22;37(10):1844-1856. doi: 10.1093/ndt/gfac156.
9
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference.动脉粥样硬化性肾血管疾病:KDIGO(肾脏病:改善全球预后)争议会议。
Am J Kidney Dis. 2022 Feb;79(2):289-301. doi: 10.1053/j.ajkd.2021.06.025. Epub 2021 Aug 9.
10
Stem Cell Therapy for Microvascular Injury Associated with Ischemic Nephropathy.干细胞治疗缺血性肾病相关的微血管损伤。
Cells. 2021 Mar 31;10(4):765. doi: 10.3390/cells10040765.

本文引用的文献

1
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
2
Simvastatin abates development of renal fibrosis in experimental renovascular disease.辛伐他汀可减轻实验性肾血管疾病中肾纤维化的发展。
J Hypertens. 2008 Aug;26(8):1651-60. doi: 10.1097/HJH.0b013e328302833a.
3
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease.HMG-CoA还原酶抑制剂(他汀类药物)对肾脏疾病进展的影响。
Kidney Int. 2008 Sep;74(5):571-6. doi: 10.1038/ki.2008.231. Epub 2008 Jun 4.
4
The effects of statins on the progression of atherosclerotic renovascular disease.他汀类药物对动脉粥样硬化性肾血管疾病进展的影响。
Nephron Clin Pract. 2007;107(2):c35-42. doi: 10.1159/000107552. Epub 2007 Aug 21.
5
Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001.1996年至2001年美国老年患者开始透析时的动脉粥样硬化性肾血管疾病
Circulation. 2007 Jan 2;115(1):50-8. doi: 10.1161/CIRCULATIONAHA.106.637751. Epub 2006 Dec 18.
6
Unilateral nephrectomy in hypertensive disease.高血压疾病中的单侧肾切除术。
J Urol. 1956 Dec;76(6):685-701. doi: 10.1016/S0022-5347(17)66752-1.
7
Revisiting the role of nephrectomy for advanced renovascular disease.重新审视肾切除术在晚期肾血管疾病中的作用。
Am J Med. 2003 Jun 15;114(9):729-35. doi: 10.1016/s0002-9343(03)00161-x.
8
Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.高胆固醇血症合并肾动脉狭窄时肾脏结构改变的机制
Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1295-301. doi: 10.1161/01.ATV.0000077477.40824.52. Epub 2003 May 15.
9
Pathophysiology of ischemic nephropathy.缺血性肾病的病理生理学
Urol Clin North Am. 2001 Nov;28(4):793-803, ix. doi: 10.1016/s0094-0143(01)80034-3.
10
Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy.强化降脂治疗使动脉粥样硬化性肾动脉狭窄消退
J Hum Hypertens. 2001 Jun;15(6):431-3. doi: 10.1038/sj.jhh.1001196.

动脉粥样硬化性肾动脉狭窄继发缺血性肾病:临床与组织病理学相关性。

Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates.

机构信息

Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Nephrol Dial Transplant. 2010 Nov;25(11):3615-22. doi: 10.1093/ndt/gfq269. Epub 2010 May 25.

DOI:10.1093/ndt/gfq269
PMID:20501460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2957590/
Abstract

BACKGROUND

Advanced renal artery stenosis (RAS) may cause progressive deterioration in renal function. We correlated the histopathological findings and clinical characteristics in selected patients with atherosclerotic RAS who underwent nephrectomy of their small kidneys for resistant renovascular hypertension.

METHODS

We studied 62 patients who underwent nephrectomy of a small kidney for uncontrolled hypertension between 1990 and 2000.

RESULTS

The mean patient age was 65.4 ± 9.6 years; 28 (45%) were men. Significant tubulointerstitial atrophy with relative glomerular sparing was the predominant pattern of injury in 44 (71%) patients. In 14 (23%) patients, diffuse global glomerulosclerosis was present. The severity of tubulointerstitial atrophy and the extent of glomerulosclerosis were both associated with smaller kidney size (P = 0.002). Three patterns of vascular involvement were present: atheroembolic, atherosclerotic and hypertensive vascular changes, which were documented in 39, 98 and 52% of subjects, respectively. The presence and severity of these vascular changes positively correlated with both atherosclerotic risk factors, such as hypertension, dyslipidaemia and renal insufficiency, and cardiovascular morbidity, including abdominal aortic aneurysm and myocardial infarction. Patients on statin therapy were noted to have less evidence of renal fibrosis as measured by transforming growth factor-beta staining (P = 0.003).

CONCLUSION

The severity of renal histopathological findings in patients who underwent nephrectomy for resistant hypertension correlated with an increased prevalence of cardiovascular disease, a greater degree of renal dysfunction and more severe dyslipidaemia. Statin therapy may affect development of intra-renal injury by slowing the progression of fibrosis.

摘要

背景

晚期肾动脉狭窄(RAS)可能导致肾功能进行性恶化。我们对因难治性肾血管性高血压而行小肾切除术的动脉粥样硬化性 RAS 患者的组织病理学发现和临床特征进行了相关分析。

方法

我们研究了 1990 年至 2000 年间因未控制的高血压而行小肾切除术的 62 例患者。

结果

患者的平均年龄为 65.4 ± 9.6 岁,28 例(45%)为男性。44 例(71%)患者以肾小管间质明显萎缩伴相对肾小球保留为主要损伤模式。14 例(23%)患者弥漫性肾小球球性硬化。肾小管间质萎缩的严重程度和肾小球硬化的程度均与小肾体积有关(P = 0.002)。存在三种血管受累模式:动脉粥样栓塞性、动脉粥样硬化性和高血压性血管改变,分别见于 39%、98%和 52%的患者。这些血管变化的存在和严重程度与动脉粥样硬化危险因素(如高血压、血脂异常和肾功能不全)以及心血管疾病发病率(包括腹主动脉瘤和心肌梗死)呈正相关。经他汀类药物治疗的患者,经转化生长因子-β染色证实,肾纤维化的证据较少(P = 0.003)。

结论

行小肾切除术治疗难治性高血压患者的肾组织病理学发现的严重程度与心血管疾病的患病率增加、肾功能不全程度加重和血脂异常更严重相关。他汀类药物治疗可能通过减缓纤维化的进展来影响肾内损伤的发展。